Dissolved and financials
CVR: 38126881
DKK 0
Gross profit
Net result: DKK 0
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 27 October 2021
CVR · view overview
No headcount reported
Director role ended: Claus Felby
CVR · 19/08/2021
View the full event history
LJOS IVS was a Danish company of the type Iværksætterselskab based in Veksø Sjælland, founded in 2016. The company has been dissolved on 27 October 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2019 report amounted to DKK 0.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201901/01/2019 – 31/12/2019 | 0 | 0 | 0 | 0 | - | |
| 201801/01/2018 – 31/12/2018 | 0 | 0 | 0 | 0 | - |
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringNo. LJOS IVS is registered in the Danish CVR register with the status Dissolved and ceased on 27 October 2021.
The CVR number of LJOS IVS is 38126881.
In 2019, LJOS IVS reported a gross profit of DKK 0.
LJOS IVS was founded on 20 October 2016.
LJOS IVS was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi (industry code 721100).
LJOS IVS was located at Skovvangsvej 17, 3670 Veksø Sjælland.
LJOS IVS was dissolved on October 27, 2021.
As of August 19, 2021, Claus Felby has stepped down as director of LJOS IVS.
As of August 19, 2021, David Cannella has stepped down as suppleant of LJOS IVS.
As of August 19, 2021, Benedikt Blossom has stepped down as suppleant of LJOS IVS.
LJOS IVS has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK 0.
LJOS IVS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK 0.
LJOS IVS has published its interim report for the period October 20, 2016 – December 31, 2017.
As of October 20, 2016, Claus Felby is registered as director of LJOS IVS.
As of October 20, 2016, David Cannella is registered as suppleant of LJOS IVS.
As of October 20, 2016, Benedikt Blossom is registered as suppleant of LJOS IVS.
LJOS IVS was founded on October 20, 2016.
